No Data
No Data
Express News | Guardant Health Inc : Piper Sandler Raises Target Price to $50 From $34
Guardant Health Is Maintained at Sector Outperform by Scotiabank
Scotiabank Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $52
Guardant Health Is Maintained at Buy by Canaccord Genuity
Guardant Health Price Target Raised to $60.00/Share From $42.00 by Canaccord Genuity
CCORF Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $60
Buy n Die Together❤ :
Lean Investment Buy n Die Together❤ : nice lah.
Aaron Invests (AI) : Guess what my AI bot tell me to research? Healthcare!![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Ttowbin23 : a very good article
74927717 : A very good article.
View more comments...